Takeover shows interest in Chinese biotech companies

Yet another international biotech group acquires a successful Chinese company. Genmab AS from Copenhagen buys ProfoundBio, which has developed new cancer therapies, for 1.8 billion US dollars.

CK
07. April 2024

Sign up now and continue reading immediately

No credit card details required. No automatic renewal.

Sie haben bereits das Table.Briefing Abonnement?

Anmelden und weiterlesen

Last updated: 24. July 2025